Grantham Mayo Van Otterloo & Co. LLC Buys 1,235 Shares of Fabrinet $FN

Grantham Mayo Van Otterloo & Co. LLC increased its stake in shares of Fabrinet (NYSE:FN) by 1.3% during the third quarter, HoldingsChannel reports. The fund owned 98,229 shares of the technology company’s stock after buying an additional 1,235 shares during the period. Grantham Mayo Van Otterloo & Co. LLC’s holdings in Fabrinet were worth $35,816,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Munich Reinsurance Co Stock Corp in Munich bought a new position in Fabrinet during the 3rd quarter worth about $2,923,000. First Trust Advisors LP grew its holdings in shares of Fabrinet by 41.7% during the third quarter. First Trust Advisors LP now owns 3,277 shares of the technology company’s stock worth $1,195,000 after buying an additional 964 shares in the last quarter. Systematic Alpha Investments LLC acquired a new stake in Fabrinet in the 3rd quarter valued at approximately $474,000. Barclays PLC lifted its stake in Fabrinet by 3.0% in the 3rd quarter. Barclays PLC now owns 84,154 shares of the technology company’s stock valued at $30,684,000 after acquiring an additional 2,478 shares in the last quarter. Finally, IFG Advisory LLC lifted its stake in Fabrinet by 17.5% in the 3rd quarter. IFG Advisory LLC now owns 10,767 shares of the technology company’s stock valued at $3,926,000 after acquiring an additional 1,606 shares in the last quarter. 97.38% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

FN has been the subject of several research reports. Barclays raised their price target on shares of Fabrinet from $537.00 to $548.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 3rd. Susquehanna increased their target price on shares of Fabrinet from $550.00 to $570.00 and gave the stock a “positive” rating in a report on Thursday, January 22nd. Needham & Company LLC reaffirmed a “buy” rating and issued a $540.00 target price on shares of Fabrinet in a research report on Tuesday, February 3rd. Rosenblatt Securities reiterated a “buy” rating and issued a $550.00 price target on shares of Fabrinet in a research note on Tuesday, February 3rd. Finally, Northland Securities set a $600.00 price target on shares of Fabrinet in a research report on Monday, December 22nd. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $541.25.

Fabrinet Trading Down 10.1%

NYSE FN opened at $489.66 on Friday. The company has a market cap of $17.54 billion, a PE ratio of 46.90 and a beta of 1.01. Fabrinet has a 12 month low of $148.55 and a 12 month high of $632.99. The stock has a 50 day moving average of $495.79 and a 200-day moving average of $438.28.

Fabrinet (NYSE:FN) last released its earnings results on Monday, February 2nd. The technology company reported $3.36 earnings per share for the quarter, beating the consensus estimate of $3.26 by $0.10. Fabrinet had a net margin of 9.69% and a return on equity of 18.69%. The business had revenue of $1.13 billion during the quarter, compared to analysts’ expectations of $1.08 billion. During the same period last year, the business earned $2.61 earnings per share. The firm’s revenue was up 35.9% on a year-over-year basis. Fabrinet has set its Q3 2026 guidance at 3.450-3.600 EPS. As a group, sell-side analysts predict that Fabrinet will post 9.4 EPS for the current fiscal year.

Fabrinet Company Profile

Fabrinet is a global provider of advanced optical packaging and precision optical, electro‐mechanical and electronic manufacturing services (CEM). The company specializes in complex manufacturing processes for original equipment manufacturers (OEMs) in communications, data center, industrial, instrumentation and medical markets. Key capabilities include high‐precision fiber alignment, micro‐assembly, testing and diagnostics, and integration of electro‐optic subassemblies.

Incorporated in 2000, Fabrinet operates under a corporate structure headquartered in Singapore with additional regional offices and design centers in the Americas, Europe and Asia.